AIG

(redirected from Anthrax Immune Globulin)
Category filter:
AcronymDefinition
AIGAddressee Indicator Group (US DoD)
AIGAmerican International Group, Inc
AIGAnswers in Genesis (religious group in defense of Scripture)
AIGArtificial Intelligence Group
AIGAustralian Industry Group
AIGAsian Indoor Games (est. 2005)
AIGAssistant Inspector General
AIGApprenticeship Incentive Grant (Canada)
AIGAnthrax Immune Globulin (antitoxin)
AIGAcademically and Intellectually Gifted
AIGAdditional Inspector General (Nepal and Pakistan)
AIGAlternative Investments Group
AIGAdvertising Information Group (Brussels, Belgium)
AIGAquilini Investment Group (Canada)
AIGAddress Indicator Group
AIGAssociation Internationale de Géodésie (French: International Association of Geodesy)
AIGAddress Indicating Group
AIGAir Intelligence Group
AIGArbeitsgemeinschaft für Informationsverarbeitung in Gynäkologie Und Geburtshilfe
AIGApollo Invest Group
AIGAirbus Industries Group
AIGAssociation Internationale de Gérontologie (International Association of Gerontology)
AIGAddress Information Group
AIGArmy Initiatives Group
AIGAdvanced Instrumentation Group
AIGAssistant Instructor in Gunnery (Canadian and British Military)
AIGAcquisition Improvement Group
AIGAging Interest Group (various universities)
AIGAuthentication Implementation Guide
AIGAntitrust and Indemnity Group
AIGAddressee Identification Group
AIGAtomic Interactive Group, LLC (Dayton, OH)
AIGArchitecture Integration Group
AIGAin't I Great
AIGAsociación de Industriales de Guatemala (Association of Industrialists of Guatemala 1929-34)
AIGAmplifier Interface Group
AIGAssociation Intercommunale du Gourma (French: Intercommunal Gourma Association)
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
Anthrax immune globulin intravenous (AIG-IV; current trade name Anthrasil, manufactured by Emergent BioSolutions Inc., Rockville, MD, USA) is one of the few antitoxin agents approved by the Food and Drug Administration (FDA) and included in the Strategic National Stockpile (10).
Assess recommendations for the management of systemic anthrax and the use of anthrax immune globulin intravenous (AIG-IV)
Strategic National Stockpile: BAT (Botulism Antitoxin (Equine) Hep-tavalent), VIGIV (Vaccinia Immune Globulin Intravenous (Human)), and /MGR/ (Anthrax Immune Globulin Intravenous), and four approved specialty products: WinRho SDF (Rho(D) Immune Globulin Intravenous (Human)), HepaGam B (Hepatitis B Immune Globulin (Human) Injection), VARIZIG (Varicella Zoster Immune Globulin (Human)), and episil.
government, including development contracts related to the development of the company's anthrax immune globulin and anthrax monoclonal antibody product candidates, and BioThrax[R] product extensions.
Contents Overview of Project BioShield Project BioShield Procurement Process DHS Roles HHS Roles Presidential Roles Interagency Roles Appropriations, Rescissions, and Future Funding Options Appropriations Rescissions Future Funding Options Acquisitions Anthrax rPA Vaccine AVA Vaccine Abthrax Anthrax Immune Globulin Botulinum Toxin Radiological and Nuclear Agents Potassium Iodide Chelators Differences in HHS Contract Awards and Annual Budget Document Accounting Remaining Available Funds Concluding Observations List of Figures Figure 1.
Anthrax Immune Globulin. Anthrax Immune Globulin is also an antibody-based therapeutic.
Emergent's portfolio of biodefense products to protect against biological attacks include: BioThrax, an FDA approved anthrax vaccine, which is being sold to the United States government, among other customers, anthrax immune globulin for treatment of inhalational anthrax, next generation anthrax vaccines, and recombinant botulinum and botulinum toxoid vaccines.
Twelve (44%) of the 27 patients received anthrax immune globulin. We found no significant difference in the proportions of survivors and nonsurvivors who received anthrax immune globulin (p = 0.93, Figure 4) or in the median (IQR) time (days) to treatment (3 [1-3] vs.
Anthrax immune globulin intravenous (human) (AIGIV) was approved for patient 1, but was not given because she had improved by the time of its arrival.
His condition was treated with anti-microbial drugs, according to published recommendations, supplemented with anthrax immune globulin, and he fully recovered (11).
Anthrax immune globulin (AIG) was requested from CDC on day 4 and administered on day 5 without adverse reaction.